Kassberg Thomas Richard
- SEC CIK
- 0001303811
No open-market purchases or sales filed in the past year.
Current role at each company
- PASG Passage BIO, Inc.Directoras of May 21, 2026
- RARE Ultragenyx Pharmaceutical Inc.CBO & EVPas of Mar 4, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kassberg Thomas Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RARE Ultragenyx Pharmaceutical Inc.
CBO & EVP8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Kassberg Thomas RichardCBO & EVP | SSale | −6.03K | $42.10 | −$253.8K | −2.2%265.2K after | |
| Mar 12, 2024 (view filing) | Mar 11 | 1 day | Kassberg Thomas RichardCBO & EVP | SSale | −11.5K | $49.93 | −$574.6K | −4.4%252.8K after | |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Kassberg Thomas RichardCBO & EVP | SSale | −1.01K | $53.76 | −$54.4K | −0.4%264.3K after | |
| Oct 24, 2023 (view filing) | Oct 23 | 1 day | Kassberg Thomas RichardCBO & EVP | SSale | −39.9K | $32.78 | −$1.31M | −13.9%246.9K after | 10b5-1 |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Kassberg Thomas RichardCBO & EVP | SSale | −1.97K | $45.27 | −$89.1K | −0.8%250.3K after | |
| Mar 15, 2022 (view filing) | Mar 11 | 4 days | Kassberg Thomas RichardCBO & EVP | SSale | −10.3K | $67.01 | −$688.9K | −4.3%227.6K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Kassberg Thomas RichardCBO & EVP | SSale | −2.37K | $66.62 | −$158.2K | −1.1%213.8K after | |
| Oct 18, 2021 (view filing) | Oct 14 | 4 days | Kassberg Thomas RichardCBO & EVP | SSale | −286 | $81.14 | −$23.2K | −0.1%216.3K after |